| 000 | 01661 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513201213.0 | ||
| 264 | 0 | _c20000105 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0306-4522 | ||
| 024 | 7 |
_a10.1016/s0306-4522(96)83015-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsou, K | |
| 245 | 0 | 0 |
_aSuppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. _h[electronic resource] |
| 260 |
_bNeuroscience _cFeb 1996 |
||
| 300 |
_a791-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGene Expression Regulation _xphysiology |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aPain _xphysiopathology |
| 650 | 0 | 4 | _aPhysical Stimulation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptors, Cannabinoid |
| 650 | 0 | 4 |
_aReceptors, Drug _xdrug effects |
| 650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLowitz, K A | |
| 700 | 1 | _aHohmann, A G | |
| 700 | 1 | _aMartin, W J | |
| 700 | 1 | _aHathaway, C B | |
| 700 | 1 | _aBereiter, D A | |
| 700 | 1 | _aWalker, J M | |
| 773 | 0 |
_tNeuroscience _gvol. 70 _gno. 3 _gp. 791-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0306-4522(96)83015-6 _zAvailable from publisher's website |
| 999 |
_c10582692 _d10582692 |
||